Spectral Diagnosis of Cutaneous Malignancy

Completed

Conditions studied: Skin Cancer

In brief

The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can be used to detect skin cancers.

Key facts

Study ID

NCT00476905

Run by

M.D. Anderson Cancer Center

People needed

350

Starts

2007-04-01

Expected to finish

2018-11-20

Last updated by the study team

2019-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female and over 18 years of age.
• Patients undergoing an examination of their skin
• Patients with a lesion(s) in one of the five categories: basal cell carcinoma, squamous cell carcinoma, pre-cancer lesions, pigmented lesions, and benign lesions
• Patients whose lesion also warrants a biopsy.
• Signed informed consent document.

You may not qualify if…

• Patients with absence of skin lesion(s) in one of the five categories.
• Patients whose identified lesion did not need a biopsy.
• Patients who did not sign the informed consent and agree to participate.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.